Article info

Download PDFPDF

DUETTE: a phase II randomized, multicenter study to investigate the efficacy and tolerability of a second maintenance treatment in patients with platinum-sensitive relapsed epithelial ovarian cancer, who have previously received poly(ADP-ribose) polymerase (PARP) inhibitor maintenance treatment

Authors

  1. Correspondence to Dr Amit M Oza, Princess Margaret Cancer Centre, Toronto, M5G 2M9, Canada; amit.oza{at}uhn.ca
View Full Text

Citation

McMullen M, Karakasis K, Loembe B, et al
DUETTE: a phase II randomized, multicenter study to investigate the efficacy and tolerability of a second maintenance treatment in patients with platinum-sensitive relapsed epithelial ovarian cancer, who have previously received poly(ADP-ribose) polymerase (PARP) inhibitor maintenance treatment

Publication history

  • Accepted June 29, 2020
  • First published September 2, 2020.
Online issue publication 
January 08, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.